# Effects of SQ109 on QTc Interval in Healthy Subjects

> **NCT01874314** · PHASE1 · WITHDRAWN · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)**

## Conditions studied

- Tuberculosis

## Interventions

- **DRUG:** SQ109
- **OTHER:** SQ109 Placebo
- **DRUG:** Moxifloxacin

## Key facts

- **NCT ID:** NCT01874314
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2014-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01874314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01874314, "Effects of SQ109 on QTc Interval in Healthy Subjects". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01874314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*